Overall and comparative frequencies of the signs or symptoms defined to be suggestive of end-organ damage in patients receiving either nicardipine or labetalol
| Sign/symptom of EOD (n, (%)) | Overall (n=141) | Nicardipine (n=70) | Labetalol (n=71) |
|---|---|---|---|
| Shortness of breath | 61 (43.3) | 34 (48.6) | 27 (38.0) |
| Chest pain | 59 (41.8) | 33 (47.1) | 26 (36.6) |
| Syncope/dizziness | 43 (30.5) | 16 (22.9) | 27 (38.0) |
| Blurred vision/diplopia | 38 (27.0) | 19 (27.1) | 19 (26.8) |
| Epigastric discomfort | 24 (17.0) | 11 (15.7) | 13 (18.3) |
| Confusion | 8 (5.6) | 4 (5.7) | 4 (5.6) |
| Diminished level of consciousness | 6 (4.3) | 1 (1.4) | 5 (7.0) |
| Haematuria | 3 (2.1) | 2 (2.9) | 1 (1.4) |